Protein detail

UPAR

Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87)

Entry name
UPAR
UniProt ID
EVMP confidence score
0.50
Supporting publications (n)
2
Transmembrane count
Protein classification
Cancer-related genesCD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information11
Protein Names
Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87)
Protein Class (5)
Cancer-related genesCD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
Protein Function (4)
  • Cancer-related genes:Candidate cancer biomarkers
  • CD markers
  • Predicted intracellular proteins
  • FDA approved drug targets:Biotech drugs
Entrez Gene Symbol
Gene Synonym (3)
CD87UPARURKR
Gene Description
Plasminogen activator, urokinase receptor
Chromosome
19
Position
43646095-43670547
Supporting publications (n)
2
EVMP confidence score
0.50
Fluorescence & Localization3
Cell SpecificAstrocytesSingle-Nuclei Brain SpecificastrocyteBlood Cell Specificneutrophil
Function & Pathway7
Protein Function (4)
  • Cancer-related genes:Candidate cancer biomarkers
  • CD markers
  • Predicted intracellular proteins
  • FDA approved drug targets:Biotech drugs
Mediation Categories (6)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence59

Enzyme-Mediated Modification (1)

1 record.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
PLAURMMP12P39900T108cleavageHPRDHPRD:12195704

Ligand-Receptor Signaling (51)

51 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membraneplasma_membraneCellinkerNoNoYesYesYes
plasma_membraneplasma_membraneOmniPathNoNoYesYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneHPMRNoNoYesYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathNoNoYesYesYes
plasma_membrane_peripheralplasma_membrane_peripheralCSPANoNoYesYesYes
plasma_membrane_peripheralplasma_membrane_peripheralOmniPathNoNoYesYesYes
secretedsecretedUniProt_keywordNoNoYesYesYes
secretedsecretedOmniPathNoNoYesYesYes
cell_surfacecell_surfaceSurfaceomeNoNoYesYesYes
cell_surfacecell_surfaceconnectomeDB2020NoNoYesYesYes
Page 4 of 6PreviousNext

Protein Complex Composition (3)

3 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
PLAUR-PLAU complexPLAUPLAURP00749Q034054:4CORUMComplexPortalPDBintact:EBI-11890834CORUM:7112PDB:3u73PDB:2i9bPDB:2fd61689240201339422228576116456079100921052567169414755292392021616979660
uPA-uPAR-vitronectin complexPLAUPLAURVTNP00749P04004Q034051:1:1ComplexPortalPDBPDB:3bt2PDB:3u73PDB:2i9bintact:EBI-11892130PDB:4k24PDB:3bt124465541147552921837641510722842
PLAURQ034058PDBPDB:7v63PDB:7e17PDB:1ywh

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry128914500
Sequence, Structure & Domains10

Sequences

Length
335
Mass
36,978
Sequence
MGHPPLLPLLLLLHTCVPASWGLRCMQCKTNGDCRVEECALGQDLCRTTIVRLWEEGEELELVEKSCTHSEKTNRTLSYRTGLKITSLTEVVCGLDLCNQGNSGRAVTYSRSRYLECISCGSSDMSCERGRHQSLQCRSPEEQCLDVVTHWIQEGEEGRPKDDRHLRGCGYLPGCPGSNGFHNNDTFHFLKCCNTTKCNEGPILELENLPQNGRQCYSCKGNSTHGCSSEETFLIDCRGPMNQCLVATGTHEPKNQSYMVRGCATASMCQHAHLGDAFSMNHIDVSCCTKSGCNHPDLDVQYRSGAAPQPGPAHLSLTITLLMTARLWGGTLLWT
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; Synonyms=uPAR1, GPI-anchored; IsoId=Q03405-1; Sequence=Displayed; Name=2; Synonyms=uPAR2, Secreted; IsoId=Q03405-2; Sequence=VSP_006715; Name=3; IsoId=Q03405-3; Sequence=VSP_046345, VSP_046346
Alternative Sequence
158..202; Missing (in isoform 3); 203; I -> V (in isoform 3); 253..335; PKNQSYMVRGCATASMCQHAHLGDAFSMNHIDVSCCTKSGCNHPDLDVQYRSGAAPQPGPAHLSLTITLLMTARLWGGTLLWT -> RSLWGSWLPCKSTTALRPPCCEEAQATHV (in isoform 2)

3D Structural Models

Turn
96..99; 122..130; 196..199; 223..225; 229..231; 252..255; 291..294
Helix
206..208; 266..268; 275..278; 296..298
Beta Strand
24..28; 34..38; 45..54; 60..68; 75..81; 84..93; 110..114; 116..121; 133..136; 138..141; 143..150; 155..158; 164..171; 176..183; 186..193; 211..222; 226..228; 233..238; 243..251; 256..264; 270..273; 284..288
3D Structure
X-ray crystallography (11)

Domain & Motif Annotations

Domain (FT)
23..114; UPAR/Ly6 1; 115..213; UPAR/Ly6 2; 214..305; UPAR/Ly6 3
Clinical Relevance9
Disease Involvement (2)
Cancer-related genesFDA approved drug targets
Biomarker
Phase 1/2; Approved; Phase 3
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000122861
Interaction Count
1
Interaction Dataset
intact_biogrid
Supporting Publications2
PMIDTitleAbstract
30915084Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton.No abstract available
37670049Proteomic and functional characterisation of extracellular vesicles from collagen VI deficient human fibroblasts reveals a role in cell motility.No abstract available